Customized media development services can help increase titer, improve protein quality, and reduce drug discovery and commercial production costs.

With strong R&D capabilities, a large library of in-house media formulations and a high-throughput screening-based iBioG-Med serum-free media development platform, BioEngine can provide a series of customized services, such as medium formulation development for specific projects, process enhancement for fine-tuning and controlling of critical quality attributes (glycoform, charge heterogeneity, acidic peaks,  fragmentation, sialic acid, etc.) of drugs, and production of customized media. BioEngine can not only quickly obtain high-performance medium formulation, which can increase the efficiency by 30-50% compared with traditional strategies, but also accurately identify key components and quickly determine the effective concentration range, providing scientific basis and guidance for quality control of subsequent commercial production of dry powder medium.